Literature DB >> 21502252

Active surveillance for adverse events: the experience of the Vaccine Safety Datalink project.

W Katherine Yih1, Martin Kulldorff, Bruce H Fireman, Irene M Shui, Edwin M Lewis, Nicola P Klein, James Baggs, Eric S Weintraub, Edward A Belongia, Allison Naleway, Julianne Gee, Richard Platt, Tracy A Lieu.   

Abstract

OBJECTIVE: To describe the Vaccine Safety Datalink (VSD) project's experience with population-based, active surveillance for vaccine safety and draw lessons that may be useful for similar efforts. PATIENTS AND METHODS: The VSD comprises a population of 9.2 million people annually in 8 geographically diverse US health care organizations. Data on vaccinations and diagnoses are updated and extracted weekly. The safety of 5 vaccines was monitored, each with 5 to 7 prespecified outcomes. With sequential analytic methods, the number of cases of each outcome was compared with the number of cases observed in a comparison group or the number expected on the basis of background rates. If the test statistic exceeded a threshold, it was a signal of a possible vaccine-safety problem. Signals were investigated by using temporal scan statistics and analyses such as logistic regression.
RESULTS: Ten signals appeared over 3 years of surveillance: 1 signal was reported to external stakeholders and ultimately led to a change in national vaccination policy, and 9 signals were found to be spurious after rigorous internal investigation. Causes of spurious signals included imprecision in estimated background rates, changes in true incidence or coding over time, other confounding, inappropriate comparison groups, miscoding of outcomes in electronic medical records, and chance. In the absence of signals, estimates of adverse-event rates, relative risks, and attributable risks from up-to-date VSD data have provided rapid assessment of vaccine safety to policy-makers when concerns about a specific vaccine have arisen elsewhere.
CONCLUSIONS: Care with data quality, outcome definitions, comparison groups, and length of surveillance are required to enable detection of true safety problems while minimizing false signals. Some causes of false signals in the VSD system were preventable and have been corrected, whereas others will be unavoidable in any active surveillance system. Temporal scan statistics, analyses to control for confounding, and chart review are indispensable tools in signal investigation. The VSD's experience may inform new systems for active safety surveillance.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21502252     DOI: 10.1542/peds.2010-1722I

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  38 in total

1.  Exact sequential analysis for multiple weighted binomial end points.

Authors:  Ivair R Silva; Joshua J Gagne; Mehdi Najafzadeh; Martin Kulldorff
Journal:  Stat Med       Date:  2019-11-25       Impact factor: 2.373

2.  Evaluation of the 2010 National Vaccine Plan Mid-course Review: Recommendations From the National Vaccine Advisory Committee: Approved by the National Vaccine Advisory Committee on February 7, 2017.

Authors: 
Journal:  Public Health Rep       Date:  2017-06-23       Impact factor: 2.792

3.  On Designs for Vaccine Surveillance.

Authors:  Robert W Platt
Journal:  Drug Saf       Date:  2016-12       Impact factor: 5.606

4.  Orphan therapies: making best use of postmarket data.

Authors:  Judith C Maro; Jeffrey S Brown; Gerald J Dal Pan; Lingling Li
Journal:  J Gen Intern Med       Date:  2014-08       Impact factor: 5.128

5.  Vaccine Case-Population: A New Method for Vaccine Safety Surveillance.

Authors:  Hélène Théophile; Nicholas Moore; Philip Robinson; Bernard Bégaud; Antoine Pariente
Journal:  Drug Saf       Date:  2016-12       Impact factor: 5.606

6.  Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020.

Authors:  Sarah A Mbaeyi; Catherine H Bozio; Jonathan Duffy; Lorry G Rubin; Susan Hariri; David S Stephens; Jessica R MacNeil
Journal:  MMWR Recomm Rep       Date:  2020-09-25

7.  Exact conditional maximized sequential probability ratio test adjusted for covariates.

Authors:  Ivair R Silva; Lingling Li; Martin Kulldorff
Journal:  Seq Anal       Date:  2019-05-13       Impact factor: 0.927

8.  Counter-Point: Early Warning Systems Are Imperfect, but Essential.

Authors:  Christine Y Lu; Gregory Simon; Stephen B Soumerai; Martin Kulldorff
Journal:  Med Care       Date:  2018-05       Impact factor: 2.983

9.  Data quality assessment for comparative effectiveness research in distributed data networks.

Authors:  Jeffrey S Brown; Michael Kahn; Sengwee Toh
Journal:  Med Care       Date:  2013-08       Impact factor: 2.983

10.  Extent of maternal morbidity in a managed care population in georgia.

Authors:  F Carol Bruce; Cynthia J Berg; Peter J Joski; Douglas W Roblin; William M Callaghan; Joanna E Bulkley; Donald J Bachman; Mark C Hornbrook
Journal:  Paediatr Perinat Epidemiol       Date:  2012-08-29       Impact factor: 3.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.